If you are considering HBOT, consider this:

[Guest guest]

Thanks for the info. Like any treatment, you need to know

who your patient is and why you are doing it. If they conducted this

study on autistic children who did not have symptoms of what this is trying to

treat, then there was most likely no good result. However, if they would

have conducted the study on children known to have inflammatory markers, the

results might (and I emphasize might) have been different. My son was a

responder and so was one of my good friend’s son to mild HBOT. He

does have inflammation in his brain. We saw results for a while and then

he plateaued. We have learned that we have to pulse the treatments and

take breaks for stretches at a time. AND that was before we even knew he

had PANDAS, so I am very hopeful that since we have lowered his titers A LOT

that we could see even more gains.

I have heard good things about Thoughtful House, but I have to

say that we need to know how they screened their candidates and if the children

were treating the cause of inflammation prior to or during HBOT

treatment. I wonder…… if they did this as a stand-alone

treatment study, probably not a good test. Some

well-respected people in the autism world do not believe in one treatment or

another for various reasons and I don’t know this particular groups’

philosophy on HBOT. If anyone does, please share. We

can all learn from this information.

Heidi J.

From:

mb12 valtrex [mailto:mb12 valtrex ] On Behalf

Of Sloan

Sent: Tuesday, August 10, 2010 6:54 PM

To: mb12 valtrex

Subject: I fyou are considering HBOT, consider this:

Controlled Evaluation of the Effects of

Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum

Disorders.

Jepson B, Granpeesheh D, Tarbox J, Olive ML, Stott C, Braud S, Yoo JH,

Wakefield A, MS.

Thoughtful House Center for Children, Austin, TX, USA.

Abstract

Hyperbaric oxygen therapy (HBOT) has been used to treat individuals with

autism. However, few studies of its effectiveness have been completed. The

current study examined the effects of 40 HBOT sessions at 24% oxygen at 1.3 ATA

on 11 topographies of directly observed behavior. Five replications of multiple

baselines were completed across a total of 16 participants with autism spectrum

disorders. No consistent effects were observed across any group or within any individual

participant, demonstrating that HBOT was not an effective treatment for the

participants in this study. This study represents the first relatively

large-scale controlled study evaluating the effects of HBOT at the level of the

individual participant, on a wide array of behaviors.

PMID: 20680427 [PubMed - as supplied by publisher]

No virus

found in this incoming message.

Checked by AVG - www.avg.com

Version: 9.0.851 / Virus Database: 271.1.1/3050 - Release Date: 08/10/10

14:34:00